DBV Technologies SA (DBVT)
9.80
+0.25
(+2.62%)
USD |
NASDAQ |
Oct 09, 16:00
9.86
+0.06
(+0.61%)
Pre-Market: 20:00
DBV Technologies Cash from Investing (Quarterly) : -0.5998M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.5998M |
| March 31, 2026 | -0.3011M |
| December 31, 2025 | -0.7165M |
| September 30, 2025 | -0.2404M |
| June 30, 2025 | -0.0282M |
| March 31, 2025 | -0.375M |
| December 31, 2024 | 0.793M |
| September 30, 2024 | -0.109M |
| June 30, 2024 | 0.691M |
| March 31, 2024 | -2.132M |
| December 31, 2023 | -0.187M |
| Date | Value |
|---|---|
| September 30, 2023 | -0.322M |
| June 30, 2023 | -0.341M |
| March 31, 2023 | 0.042M |
| December 31, 2022 | -0.034M |
| September 30, 2022 | 0.152M |
| June 30, 2022 | -0.229M |
| March 31, 2022 | 0.011M |
| December 31, 2021 | -0.4733M |
| September 30, 2021 | 0.054M |
| June 30, 2021 | 0.172M |
| March 31, 2021 | -0.185M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Cellectis SA | 18.75M |
| Akari Therapeutics Plc | 0.00 |
| EDAP TMS SA | -1.262M |
| Bicycle Therapeutics Plc | -0.266M |
| Autolus Therapeutics Plc | 68.03M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -52.52M |
| Cash from Financing (Quarterly) | -0.1356M |
| Free Cash Flow | -152.18M |
| Free Cash Flow Per Share (Quarterly) | -0.58 |
| Free Cash Flow to Equity (Quarterly) | -44.30M |
| Free Cash Flow to Firm (Quarterly) | -49.68M |
| Free Cash Flow Yield | -39.08% |